Catalent Expands OneBio® Suite for Integrated Development, Manufacturing and Supply Across Biologic Modalities

FHS
June 16, 2023
12:31 pm

Catalen today announced that it has expanded its integrated development, manufacturing and supply solution, OneBio® Suite, across a range of biologic modalities, including antibody and recombinant proteins, cell and gene therapies, and mRNA.

PharmaTher Initiates Filing of Abbreviated New Drug Application for KETARX™ (racemic ketamine) to the FDA – Psychedelic Alpha

TORONTO, June 27, 2023 (GLOBE NEWSWIRE) — PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a commercial-focused specialty pharmaceutical company, is pleased

June 27, 2023

Opinion | Why Do We Tolerate Our Health Insurance Problem?

N. Adam Brown, MD, MBA, is an emergency medicine physician and business expert. In a country where the healthcare industry is driven by profit, it’s

June 21, 2023

More colonscopy news and research

Exciting news! STAT has moved its comment section to our subscriber-only app, STAT+ Connect. Subscribe to STAT+ today to join the conversation or join us

November 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.